[ERCC1 as a Marker of Ovarian Cancer Resistance to Platinum Drugs]

Autor: Ta, Bogush, As, Popova, Ea, Dudko, Ea, Bogush, As, Tyulyandina, Sa, Tyulyandin, Mi, Davydov

Publikováno v: Europe PubMed Central

The review is concerned with the crucial marker of nucleotide excision repair ERCC1 and its contribution to platinum resistance of ovarian cancer. All the variants of the laboratory and clinical ERCC1 assessment in the ovarian cancer tissue (single n

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4f6009415f0c66cad4a8c1098872c131
https://pubmed.ncbi.nlm.nih.gov/26415382

[Inhibition of ABC-transporter(s)' function in non-small cell lung cancer cells by platinum drugs]

Autor: Ta, Bogush, Av, Konukhova, Ab, Ravcheeva, Tn, Zabotina, Z.G. Kadagidze, Ea, Bogush, Dv, Komov, Be, Polotskiĭ, Kk, Laktionov, Mi, Davydov

Publikováno v: Europe PubMed Central

With an account of the literature data that platinum drugs react with many cellular targets, including ATP and proteins, the authors suggested that disturbance of the function of energy-dependent ABC-transporters (markers of multidrug resistance, MDR

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7d2a0b5ff7e88e263ad39a45e9188284
https://pubmed.ncbi.nlm.nih.gov/15004974

Flow cytometric analysis of the ERCC1, marker of DNA damage repair, in the tumor specimens embedded into paraffin blocks.

Autor: Bogush TA; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia. tatbogush@mail.ru., Dudko EA; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia., Grishanina AN; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia., Zarkua VT; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia., Bogush EA; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia., Basharina AA; Faculty of Fundamental Medicine, Moscow State University, Moscow, 1192324, Russia., Polotsky BE; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia., Tjulandin SA; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia., Davydov MM; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia., Davydov MI; N.N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation, Moscow, 115478, Russia.

Publikováno v: Doklady. Biochemistry and biophysics [Dokl Biochem Biophys] 2017 Jan; Vol. 472 (1), pp. 9-11. Date of Electronic Publication: 2017 Apr 19.

New Data on Molecular Targets of Tamoxifen Besides Estrogen Receptors, Their Clinical Significancy.

Autor: Bogush TA, Polezhaev BB, Dudko EA, Bogush EA, Kirsanov VY, Polotsky BE, Tjuljandin SA, Davydov MI

Publikováno v: Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] [Antibiot Khimioter] 2016 Aug; Vol. 61, pp. 41-49.

[Right-sided hemicolectomy with gastropancreatoduodenectomy for complicated right-sided locally-advanced colon cancer in elder patient].

Autor: Davydov MI; Department of Coloproctology, Blokhin Russian Research Oncology Center, Moscow, Russia., Rasulov AO; Department of Coloproctology, Blokhin Russian Research Oncology Center, Moscow, Russia., Tamrazov RI; Department of Coloproctology, Blokhin Russian Research Oncology Center, Moscow, Russia., Nekhaev IV; Department of Coloproctology, Blokhin Russian Research Oncology Center, Moscow, Russia.

Publikováno v: Khirurgiia [Khirurgiia (Mosk)] 2016 (7), pp. 72-76.